ARUP Laboratories:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ARUP Laboratories - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7076
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ARUP Laboratories (ARUP) is a clinical and anatomical pathology reference laboratory. It is a nonprofit enterprise of the University of Utah and its Department of Pathology. The company provides several tests and test combinations in the fields of anatomic pathology, genetics, pain management, general oncology, hematologic oncology, hemostasis/thrombosis, immuno-hematology, molecular infectious disease, pediatric conditions, transplantation, and veterinary pathology. The company performs 99% of tests on site. Its major clients include university teaching hospitals, children’s hospitals, regional hospital networks, major commercial laboratories and clinics, group-purchasing organizations, and military and government facilities. ARUP is headquartered in Salt Lake City, Utah, the US.

ARUP Laboratories – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ARUP Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ARUP Laboratories, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ARUP Laboratories, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ARUP Laboratories, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ARUP Laboratories, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ARUP Laboratories, Medical Equipment, Deal Details 10
Venture Financing 10
PierianDx Raises USD9.2 Million in Series A Financing Round 10
Partnerships 11
IDbyDNA Enters into Agreement with ARUP Laboratories 11
Applied Spectral Imaging Enters into Agreement with ARUP Labs 12
Arup Labs Enters into Agreement with University Hospital Case Medical Center to Distribute Novel DEEPGEN HIV Test 13
Predictive Biosciences Enters Into Co-Marketing Agreement With Arup Labs For CertNDx Bladder Cancer Assays 14
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 15
ARUP Laboratories – Key Competitors 16
ARUP Laboratories – Key Employees 17
ARUP Laboratories – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Other Significant Developments 19
Dec 18, 2017: Interpace Diagnostics Announces Agreement with ARUP Laboratories 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
ARUP Laboratories, Medical Equipment, Key Facts 2
ARUP Laboratories, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ARUP Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ARUP Laboratories, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ARUP Laboratories, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ARUP Laboratories, Deals By Market, 2012 to YTD 2018 8
ARUP Laboratories, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PierianDx Raises USD9.2 Million in Series A Financing Round 10
IDbyDNA Enters into Agreement with ARUP Laboratories 11
Applied Spectral Imaging Enters into Agreement with ARUP Labs 12
Arup Labs Enters into Agreement with University Hospital Case Medical Center to Distribute Novel DEEPGEN HIV Test 13
Predictive Biosciences Enters Into Co-Marketing Agreement With Arup Labs For CertNDx Bladder Cancer Assays 14
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 15
ARUP Laboratories, Key Competitors 16
ARUP Laboratories, Key Employees 17

List of Figures
ARUP Laboratories, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ARUP Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ARUP Laboratories, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ARUP Laboratories, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ARUP Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ARUP Laboratories, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ARUP Laboratories, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ARUP Laboratories, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ARUP Laboratories:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Smith & Williamson Holdings Ltd:企業の戦略的SWOT分析
    Smith & Williamson Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Bechtel Corporation:企業の戦略的SWOT分析
    Bechtel Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Bulgarian Energy Holding EAD:企業の戦略的SWOT分析
    Bulgarian Energy Holding EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • SAS AB:戦略・SWOT・企業財務分析
    SAS AB - Strategy, SWOT and Corporate Finance Report Summary SAS AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Dako AS-製薬・医療分野:企業M&A・提携分析
    Summary Dako A/S (Dako Denmark), a subsidiary of Agilent Technologies Inc is a diagnostic company. The company’s products include diagnostic antibodies, reagents and kits, software related products, instruments and related products, clone products, and synonym products. It also provides immunohistoc …
  • DaVita Inc.:戦略・SWOT・企業財務分析
    DaVita Inc. - Strategy, SWOT and Corporate Finance Report Summary DaVita Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • HSBC Holdings Plc:企業のM&A・事業提携・投資動向
    HSBC Holdings Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HSBC Holdings Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Brown & Brown, Inc.:企業のM&A・事業提携・投資動向
    Brown & Brown, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brown & Brown, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • The Medicines Company (MDCO)-医療機器分野:企業M&A・提携分析
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products, namely, Angiomax (bivalirudin), Orbactiv (oritavancin), Minocin (minocycl …
  • Bechtel Corporation-エネルギー分野:企業M&A・提携分析
    Summary Bechtel Corporation (Bechtel) is a provider of engineering, construction and project management services. It provides a diverse portfolio of services to energy, transportation, communications, mining, oil and gas, chemicals, water, nuclear and government customers across the world. Its major …
  • Kokubu Group Corp:企業の戦略・SWOT・財務情報
    Kokubu Group Corp - Strategy, SWOT and Corporate Finance Report Summary Kokubu Group Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Brigham and Women’s Hospital:企業のM&A・事業提携・投資動向
    Brigham and Women's Hospital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brigham and Women's Hospital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • CytoDel Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CytoDel Inc (CytoDel) is a biopharmaceutical company that utilizes molecular biology tools to produce recombinant derivatives of botulinum neurotoxin (BoNT). The company provides product portfolio such as Ctyo-111, an antidote to botulism; and Cyto-012 a recombinant BoNT derivative, among ot …
  • CareDx Inc (CDNA):企業の財務・戦略的SWOT分析
    Summary CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used …
  • Hutchison China Meditech Ltd:企業の戦略・SWOT・財務分析
    Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report Summary Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Metgasco Ltd (MEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Metgasco Ltd (Metgasco) is an oil and gas exploration company. The company that acquires, explores, produces, and develops oil and gas, petroleum and hydrocarbon assets. It holds interests in Clarence Moreton Basin, an exploration license located in northern New South Wales. Metgasco supplie …
  • Magnit:企業の戦略・SWOT・財務情報
    Magnit - Strategy, SWOT and Corporate Finance Report Summary Magnit - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Volex plc (VLX):企業の財務・戦略的SWOT分析
    Volex plc (VLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Techniker Krankenkasse:企業の戦略的SWOT分析
    Techniker Krankenkasse - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a biopharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases, and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆